For instance, MIL‐based approaches have been applied to predict EGFR mutations in lung adenocarcinoma [20, 21], genetic alterations in gastric cancer [27], and mutation status in breast carcinoma [28]. Here, EGFR is linked to lung adenocarcinoma.